113 related articles for article (PubMed ID: 24018427)
1. Effect of allograft inflammatory factor-1 gene polymorphisms on rheumatoid arthritis treatment with methotrexate.
Pawlik A; Herczynska MM; Dziedziejko V; Malinowski D; Kurzawski M; Drozdzik M; Gawronska-Szklarz B
Postepy Hig Med Dosw (Online); 2013 Jul; 67():637-42. PubMed ID: 24018427
[TBL] [Abstract][Full Text] [Related]
2. Allograft inflammatory factor-1 gene polymorphisms in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Dziedziejko V; Safranow K; Paczkowska E; Maslinski W; Drozdzik M; Gawronska-Szklarz B
Genet Test Mol Biomarkers; 2012 May; 16(5):341-5. PubMed ID: 22106834
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate.
Kotrych D; Dziedziejko V; Safranow K; Pawlik A
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3037-40. PubMed ID: 26367725
[TBL] [Abstract][Full Text] [Related]
4. [Association between AIF-1 gene polymorphisms and response to rheumatoid arthritis treatment with sulphasalazine].
Dabrowska-Zamojcin E; Herczyńska MM; Pawlik A
Ann Acad Med Stetin; 2013; 59(2):39-42. PubMed ID: 25026748
[TBL] [Abstract][Full Text] [Related]
5. Effect of ESR1 and ESR2 gene polymorphisms on rheumatoid arthritis treatment with methotrexate.
Pawlik A; Dziedziejko V; Kurzawski M; Safranow K; Kotrych D; Bohatyrewicz A
Pharmacol Rep; 2012; 64(1):185-90. PubMed ID: 22580535
[TBL] [Abstract][Full Text] [Related]
6. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
7. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy.
Tolusso B; Pietrapertosa D; Morelli A; De Santis M; Gremese E; Farina G; Carniello SG; Del Frate M; Ferraccioli G
Pharmacogenomics; 2006 Jul; 7(5):683-95. PubMed ID: 16886894
[TBL] [Abstract][Full Text] [Related]
8. Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.
Lima A; Bernardes M; Azevedo R; Seabra V; Medeiros R
Pharmacogenomics; 2016 Oct; 17(15):1649-1674. PubMed ID: 27676277
[TBL] [Abstract][Full Text] [Related]
9. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.
Rizzo R; Rubini M; Govoni M; Padovan M; Melchiorri L; Stignani M; Carturan S; Ferretti S; Trotta F; Baricordi OR
Pharmacogenet Genomics; 2006 Sep; 16(9):615-23. PubMed ID: 16906016
[TBL] [Abstract][Full Text] [Related]
10. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
[TBL] [Abstract][Full Text] [Related]
11. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
[TBL] [Abstract][Full Text] [Related]
12. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.
Lima A; Seabra V; Bernardes M; Azevedo R; Sousa H; Medeiros R
PLoS One; 2014; 9(10):e108165. PubMed ID: 25279663
[TBL] [Abstract][Full Text] [Related]
13. Association of allograft inflammatory factor-1 gene polymorphism with rheumatoid arthritis.
Pawlik A; Kurzawski M; Szczepanik T; Dziedziejko V; Safranow K; Borowiec-Chłopek Z; Giedrys-Kalemba S; Drozdzik M
Tissue Antigens; 2008 Aug; 72(2):171-5. PubMed ID: 18721278
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate.
Prasad S; Tripathi D; Rai MK; Aggarwal S; Mittal B; Agarwal V
Int J Rheum Dis; 2014 Nov; 17(8):878-86. PubMed ID: 24734954
[TBL] [Abstract][Full Text] [Related]
15. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
17. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
Muralidharan N; Mariaselvam CM; Mithun CB; Negi VS
Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854
[TBL] [Abstract][Full Text] [Related]
18. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
[TBL] [Abstract][Full Text] [Related]
19. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.
Drozdzik M; Rudas T; Pawlik A; Kurzawski M; Czerny B; Gornik W; Herczynska M
Eur J Clin Pharmacol; 2006 Nov; 62(11):933-7. PubMed ID: 16932953
[TBL] [Abstract][Full Text] [Related]
20. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
